The Top E-Commerce Stock to Watch in 2023

Discover why this company's shares are rocketing this year and why insiders continue to load up Unsubscribe A Message from Trading Wire This company may come out one of the biggest winners as e-Commerce sales accelerate. As eCommerce continues to grow in popularity, the competition among retailers is expected to intensify, with those who can adapt quickly to changing trends. That’s what makes this emerging NASDAQ company so exciting. Insiders are scooping up shares and for a good reason too. This company has established itself as a market-leading Amazon and eCommerce brand owner and aggregator by acquiring profitable, data-driven Amazon and eCommerce brands. The company’s acquisitions are focused on profitable companies that have substantial consumer databases that allow the company to cross-sell existing products offered by its various brands. Most recently the company signed a non-binding Letter of Intent to acquire all the assets including working capital of a Texas-based wellness and nutrition brand specializing in the growing superfoods category with approximately $15 million in trailing twelve-month revenue for $2.5 million in a combination of cash, stock and an earn out. In line with its focus on its strategic acquisitions, the company also excitingly acquired the remaining 45% interest in Cygnet Online LLC, which sells on Amazon.com for many years. With this acquisition it has acquired 1,200 active SKUs of branded OTC products that focus on OTC, supplements, and beauty markets. Discover why this company’s shares are rocketing this year and why insiders continue to load up! Thank you for subscribing to DividendStocks.com's daily newsletter for dividend and income investors that covers ex-dividend stocks, new dividend declarations, dividend stock ideas, and the latest market news.   This message is a paid advertisement sent on behalf of Trading Wire, a third-party advertiser of DividendStocks.com and MarketBeat.     This message is a paid advertisement for Upexi, Inc. (NASDAQ: UPXI) from Interactive Offers and Trading Wire. American Consumer News, LLC dba MarketBeat receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $1,500. Other than the compensation received for this advertisement sent to subscribers, MarketBeat and its principals are not affiliated with either Interactive Offers or Trading Wire. MarketBeat and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither MarketBeat nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from MarketBeat to buy or sell any security. MarketBeat has not evaluated the accuracy of any claims made in this advertisement. MarketBeat recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Upexi, Inc. (NASDAQ: UPXI) on Trading Wire' website for additional information about the relationship between Trading Wire and Upexi, Inc. (NASDAQ: UPXI).     If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com or leave us a voicemail at (844) 978-6257.   If you no longer wish to receive email from DividendStocks.com, you can unsubscribe.   © 2006-2023 American Consumer News, LLC dba MarketBeat. 326 E 8th St #105, Sioux Falls, SD 57103. United States.   Today's Bonus Content: BREAKING: Tiny biotech successfully treats blindness